However whilst both BARD1 SNPs (rs2070096, rs2229571) in this study have been associated with nephroblastoma and neuroblastoma [35–38], no studies have associated them with response to platinum based drugs as part of a therapeutic regimen. The gene discussed is BARD1; the disease is neuroblastoma.